NCT01131091View on ClinicalTrials.gov

A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

SK-0403

SK-0403 400 mg

Trial Locations (2)

Unknown

Orlando

Minneapolis

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY